Phase 2 Triple-Negative Breast Cancer Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Triple Negative Breast Cancer and Celecoxib. Pilot Study
Triple-Negative Breast Cancer
Université de Sherbrooke30 enrolled1 locationNCT07104266
Recruiting
Phase 2
A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer
Triple-Negative Breast Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.160 enrolled1 locationNCT06492005
Recruiting
Phase 1Phase 2
A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast
Triple-Negative Breast Cancer
Jiangxi Provincial Cancer Hospital20 enrolled1 locationNCT04481763